GG
ASXC

Gleason Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Gleason Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed -$7 – 271
2024
Q2 		$7 Hold
20
– – ﹤0.01% 267
2024
Q1 		$5 Hold
20
– – ﹤0.01% 203
2023
Q4 		$6 Hold
20
– – ﹤0.01% 219
2023
Q3 		$5 Hold
20
– – ﹤0.01% 233
2023
Q2 		$10 Hold
20
– – ﹤0.01% 231
2023
Q1 		$13 Hold
20
– – ﹤0.01% 228
2022
Q4 		$7 Hold
20
– – ﹤0.01% 226
2022
Q3 		$0 Hold
20
– – ﹤0.01% 263
2022
Q2 		$0 Hold
20
– – ﹤0.01% 257
2022
Q1 		$0 Hold
20
– – ﹤0.01% 221
2021
Q4 		$0 Hold
20
– – ﹤0.01% 214
2021
Q3 		$0 Hold
20
– – ﹤0.01% 208
2021
Q2 		$0 Hold
20
– – ﹤0.01% 211
2021
Q1 		$0 Hold
20
– – ﹤0.01% 207
2020
Q4 		$0 Hold
20
– – ﹤0.01% 194
2020
Q3 		$0 Hold
20
– – ﹤0.01% 182
2020
Q2 		$0 Hold
20
– – ﹤0.01% 185
2020
Q1 		$0 Sell
20
-77
-79% -$80 ﹤0.01% 193
2019
Q4 		$0 Buy
+97
New +$337 ﹤0.01% 184

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Gleason Group's ASXC Position: Q3 2024 in Review

Gleason Group sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 20 shares — an estimated $7 sold.

Gleason Group first reported a position in ASXC in Q4 2019 and held it in 19 quarters. The position peaked at $13 in Q1 2023. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Gleason Group reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Gleason Group sold 20 Asensus Surgical, Inc. shares in Q3 2024, an estimated $7.
  • Gleason Group first reported a position in Asensus Surgical, Inc. in Q4 2019 and held it in 19 quarters.
  • Gleason Group's Asensus Surgical, Inc. position peaked at $13 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Gleason Group's 13F filing for Q3 2024, filed 15 Oct 2024.